FNY Managed Accounts LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 72 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
FNY Managed Accounts LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$4,000
+33.3%
1,000
+25.0%
0.00%
-33.3%
Q4 2017$3,000
-87.5%
800
-81.8%
0.00%
-90.3%
Q3 2017$24,000
-100.0%
4,400
-83.7%
0.03%
-32.6%
Q3 2016$54,400,00027,0200.05%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
JBF Capital, Inc. 520,553$161,0000.03%
Kalos Management, Inc. 43,940$13,0000.01%
ACADIAN ASSET MANAGEMENT LLC 1,351,000$419,0000.00%
Quilter Plc 60,546$19,0000.00%
ALBION FINANCIAL GROUP /UT 12,000$4,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$7,0000.00%
MORGAN STANLEY 1,900$1,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$8,0000.00%
BlackRock Inc. 645,611$200,0000.00%
Bank of New York Mellon Corp 137,500$43,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders